Association of dehydroepiandrosterone sulfate and testosterone deficiency with bone turnover in men with inflammatory bowel disease

International Journal of Colorectal Disease

Volumn 17, Issue 2, 2002, Pages 63-66

  Szathmári, Miklós ^a   Vásárhelyi, Barna ^a   Treszl, András ^a   Tulassay, Tivadar ^a   Tulassay, Zsolt ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Bone mineral density; Bone turnover; Dehydroepiandrosterone sulfate; Inflammatory bowel disease; Testosterone

Indexed keywords

CORTICOSTEROID; DEOXYPYRIDINOLINE; HEPARIN; OSTEOCALCIN; PRASTERONE SULFATE; PREDNISONE; STEROID; TESTOSTERONE;

ADULT; AGE; ARTICLE; BODY WEIGHT; BONE DEFECT; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DRUG USE; ENTERITIS; FEMUR NECK; HORMONE DEFICIENCY; HUMAN; INFLAMMATION; LUMBAR SPINE; MALE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; SCORING SYSTEM; STEROID THERAPY; ULCERATIVE COLITIS; URINARY EXCRETION;

ADULT; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; DEHYDROEPIANDROSTERONE SULFATE; FEMUR NECK; HUMANS; INFLAMMATORY BOWEL DISEASES; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS; TESTOSTERONE;

EID: 0036935256     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840100334     Document Type: Article

References (14)

1. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C (1997) Reduced bone density in patients with inflammatory bowel disease. Gut 40:228-233
2. De Vos M, De Keyser F, Mielants H, Cuvelier C, Veys E (1998) Bone and joint diseases in inflammatory bowel disease. Aliment Pharmacol Ther 12:397-404
3. Jahnsen J, Falch JA, Aadland E, Mowinckel P (1997) Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 40:313-319
4. Clements D, Evans WD, Compston JE, Rhodes J (1993) Hormone replacement therapy prevents bone loss in women with inflammatory bowel disease. Gut 34:1543-1546
5. Robinson RJ, Iqbal SJ, Al-Azzawi F, Abrams K, Mayberry JF (1998) Sex hormone status and bone metabolism in men with Crohn's disease. Aliment Pharmacol Ther 12:21-25
6. Robinzon B, Cutolo M (1999) Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids? Rheumatology (Oxf) 38:488-495
7. Straub-RH, Vogl D, Gross V, Lang B, Scholmerich J, Andus T (1998) Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Am J Gastroenterol 93:2197-2202
8. Torre B de la, Hedman M, Befrits R (1998) Blood and tissue dehydroepiandrosterone sulphate levels and their relationship to chronic inflammatory bowel disease. Clin Exp Rheumatol 16:579-582
9. Garnero P, Sornay Rendu E, Claustrat B, Delmas P (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526-1536
10. Szathmári M, Szücs J, Fehér T, Holló I (1994) Dehydroepiandrosterone sulphate and bone mineral density. Osteoporosis Int 4:84-88
11. Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, Couturier D, Amor B (1995) Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 108:417-422
12. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698
13. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in man. N Engl J Med 331:1056-1061
14. Ebeling P, Koivisto VA (1994) Physiological importance of dehydroepiandrosterone. Lancet 343:1479-1481